Jan 27, 2021
ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
Nov 06, 2020
ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
Oct 23, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
Aug 12, 2020
ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
Jul 29, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
Jun 17, 2020
ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
May 27, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
May 13, 2020
ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
May 06, 2020
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
May 01, 2020
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
Apr 29, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results
Apr 01, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
Mar 30, 2020
Correvio Reports Full Year 2019 Financial Results
Mar 27, 2020
ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
Mar 25, 2020
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
Mar 16, 2020
ADVANZ PHARMA to Acquire Correvio
Mar 16, 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Mar 11, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results
Mar 10, 2020
ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange
Mar 06, 2020
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million